Journal: Journal of Nanobiotechnology
Article Title: Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development
doi: 10.1186/s12951-025-03577-7
Figure Lengend Snippet: NPs-DPPA exert antiangiogenic effects through Angptl2. ( A ) Heatmap of the protein expression profiles of CAL-27 cells treated with NPs-DPPA. GO enrichment analysis ( B ) and volcano plot ( C ) of the differentially expressed proteins in CAL-27 cells treated with NPs-DPPA. Protein levels of ERK, P-ERK, VEGFa and Angptl2 in CAL-27 and SCC-7 cells ( D ) and a statistical analysis of the results (CAL-27 cells: E-H; SCC-7 cells: I-L) obtained from a western blot analysis after treatment with PBS, NPs-DPPA, ERKi, PLGA-ERKi, or NP-AE. ns, no significance; ** p < 0.01, *** p < 0.001, and **** p < 0.0001, n = 3; one-way ANOVA or two-tailed Student’s t test was used for multiple comparisons
Article Snippet: The VEGFA rabbit pAb (19003-1-AP), Angptl2 rabbit pAb (12316-1-AP), ERK rabbit pAb (11257-1-AP) and phospho-ERK rabbit pAb (28733-1-AP) were purchased from Proteintech (Wuhan, China).
Techniques: Expressing, Western Blot, Two Tailed Test